Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Alaunos Therapeutics Inc (TCRT)

Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ziopharm: Q4 Earnings Snapshot AP - Tue Mar 31, 5:47PM CDT

Ziopharm: Q4 Earnings Snapshot

TCRT : 2.92 (-0.06%)
Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders GlobeNewswire - Mon Mar 2, 5:30AM CST

The lead drug candidate, ALN1003, showed dose-related body weight loss and favorable body composition changes in the DIO mouse model ALN1003 also demonstrated reductions in liver weight and improvements...

TCRT : 2.92 (-0.06%)
Ziopharm: Q3 Earnings Snapshot AP - Fri Nov 14, 2025

Ziopharm: Q3 Earnings Snapshot

TCRT : 2.92 (-0.06%)
Ziopharm: Q2 Earnings Snapshot AP - Thu Aug 14, 2025

Ziopharm: Q2 Earnings Snapshot

TCRT : 2.92 (-0.06%)
Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering GlobeNewswire - Mon Jun 23, 2025

TCRT : 2.92 (-0.06%)
Ziopharm: Q1 Earnings Snapshot AP - Thu May 15, 2025

Ziopharm: Q1 Earnings Snapshot

TCRT : 2.92 (-0.06%)
PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT) GlobeNewswire - Wed May 14, 2025

TCRT : 2.92 (-0.06%)
ELAB : 4.63 (+34.20%)
These 3 Healthcare Stocks Show Serious Muscle Amid Trump Tariff Turmoil: Are Retail Traders Feeling Bullish? Stocktwits - Mon Apr 7, 2025

iCoreConnect, BioAffinity and Alaunos Therapeutics posted strong gains last week amid heavy trading volume.

BIAF : 3.87 (-5.38%)
TCRT : 2.92 (-0.06%)
ICCT : 0.0005 (-50.00%)
Ziopharm: Q3 Earnings Snapshot AP - Thu Nov 14, 2024

Ziopharm: Q3 Earnings Snapshot

TCRT : 2.92 (-0.06%)
Ziopharm: Q2 Earnings Snapshot AP - Thu Aug 15, 2024

Ziopharm: Q2 Earnings Snapshot

TCRT : 2.92 (-0.06%)

Barchart Exclusives

1 Trade to Make Now as U.S., Iran Agree to 2-Week Ceasefire Barchart - 21 minutes ago
June U.S. T-bond futures present a buying opportunity on more price strength. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.